Injecting Thick-Viscosity Medications: a Technique Guide for Oil-Based Injectables

For oil-based injectables (testosterone esters, Nebido, progesterone in oil), draw with an 18G or 21G needle and inject with a 23G or 25G needle — never the same needle for both. Warm the vial to body temperature first; cold oil is several times more viscous than warm and will clog thin gauges. Use the Z-track technique to seal the channel after withdrawal and prevent post-injection leakage. Inject slowly: 1 mL of oil takes 8–15 seconds through a 25G, versus 2–3 seconds for an aqueous solution.

Drawing 4 mL of testosterone undecanoate from a Nebido ampoule through a 27G needle is an exercise in patience that you do not want to repeat. The oil viscosity is too high for thin-gauge transfer, the needle clogs, you bend the bevel against the rubber stopper trying to apply force, and an hour later your forearm is sore from squeezing the plunger.

This article is for adults whose prescription includes a viscous oil-based injectable medication — testosterone esters, Nebido, progesterone in oil, certain depot estradiol formulations, B12 from glass ampoules — and who are self-administering at home. It covers the equipment choices that make the procedure straightforward, the Z-track technique that reduces post-injection leakage, and the warming and timing details that the leaflets gloss over.

It is not a substitute for the specific injection instructions provided with your medication. The SmPC and the leaflet that came in the box always take precedence on details specific to your drug.

What "viscous" means in practice

Aqueous injectables — insulin, GLP-1 medications, vaccines — flow easily through fine-gauge needles. Oil-based injectables behave differently. The vehicle is typically castor oil (Nebido), sesame oil, cottonseed oil, grapeseed oil or arachis oil, depending on the formulation. These oils have viscosities 50 to 100 times higher than water at room temperature.

The practical consequences:

• Thin gauges (27G+) are too restrictive to draw oil through within reasonable time. Forcing it produces unreliable measurement and bent bevels.
• Cold oil is much more viscous than warm oil. A vial straight from refrigerator temperature can be unworkable; the same vial at 30 °C (body warmth) draws several times faster.
• Injection takes longer. A 1 mL injection of aqueous solution takes 2–3 seconds; the same volume of oil through a 25G needle takes 8–15 seconds depending on temperature.

Equipment for oil-based IM

The standard UK equipment for self-administered IM testosterone or progesterone in oil:

Two needles per injection — one for drawing, one for injecting — is the published best practice. Drawing through the rubber stopper of a multi-dose vial dulls the bevel slightly, and using the same dulled needle for injection is more painful and more tissue-traumatic than swapping to a fresh injection needle.

For routine oil-based IM at 1 mL or less, the InjectKit 29G × 1/2 inch insulin syringe 100-pack covers the inject step, paired with an 18G or 21G drawing needle. For reconstitution from compounded oil-based formulations dispensed in multi-dose vials, the 30 mL bacteriostatic water vial covers the diluent side where the SmPC specifies reconstitution.

Warming the vial (or ampoule)

The single most-effective technique for oil-based injection is to warm the medication to body temperature before drawing. Methods, in order of practicality:

1. Hold the vial in a closed fist for 5–10 minutes before drawing. This is sufficient for most ampoule-volume preparations.
2. Place the vial in a sealed plastic bag, then in warm tap water (35–38 °C) for 5 minutes. Faster than the fist method; useful for larger Nebido vials.
3. Body-temperature pocket warming for 30 minutes. The slowest method; used by people who prefer not to handle the vial in water.

Do not use a microwave. Do not use hot water above 40 °C. Either approach can degrade the medication; the SmPCs specify storage temperatures and exposing the vial to high heat exceeds them.

Drawing the dose

1. Wash hands.
2. Prepare the vial top — wipe the rubber stopper of a multi-dose vial with an alcohol pad. For a glass ampoule, ensure the contents are settled in the bottom by gently flicking, then snap the neck (most ampoules have a printed dot indicating the snap point).
3. Attach the drawing-up needle to the syringe.
4. Draw a small volume of air equal to your intended dose if drawing from a multi-dose vial — this equalises pressure inside the vial. Do not do this for ampoules.
5. Invert the vial, insert the drawing-up needle, and pull the plunger slowly to draw the medication. For ampoules, hold the ampoule slightly tilted and place the needle below the meniscus.
6. Tap the syringe to bring air bubbles to the top, then push them out gently. Small bubbles in oil are difficult to fully eliminate but should be minimised.
7. Switch to the injection needle. Pull the drawing-up needle off the syringe and replace with a fresh injection needle. Do not re-cap the drawing needle by hand — drop it directly in the sharps bin (the WHO injection safety toolkit is unambiguous on no recapping).

Injection technique — Z-track

The Z-track technique reduces medication tracking back along the needle channel after withdrawal, which is particularly relevant for oil-based depot injections that can leak from the entry site:

1. Cleanse the injection site with an alcohol pad in a circular motion outward from the centre. Allow 5–10 seconds for the alcohol to dry.
2. With your non-injecting hand, displace the skin and subcutaneous tissue 1–2 cm laterally from the intended needle entry point.
3. Insert the needle at 90 degrees to the skin, in one smooth motion to the full length.
4. Aspirate gently for 2–3 seconds — pull the plunger back slightly. If blood appears in the syringe, withdraw the needle, discard the dose, and start over with fresh equipment. Aspiration before IM injection has been deemphasised in some recent guidance for vaccine administration but remains the conservative practice for oil-based depot injection in muscle, where intravascular injection of an oil suspension can produce serious adverse reactions.
5. Inject slowly — 1 mL over 8–10 seconds for typical oil viscosities. Faster injection produces more soreness.
6. Wait 10 seconds at the end of injection before withdrawing the needle. This allows the muscle tissue to seal around the needle channel before withdrawal.
7. Withdraw the needle smoothly, then release the displaced skin (the Z-track step). The displaced skin returns to position, sealing off the needle channel and trapping the medication in deeper tissue.
8. Apply light pressure with gauze if a small amount of blood appears at the surface. Do not massage — massage can promote tracking back of medication and increase post-injection bleeding.

The Zaybak and Khorshid 2008 study in J Adv Nurs compared Z-track to standard IM technique and found significantly less pain, bruising and post-injection leakage with Z-track in viscous IM injection. For oil-based testosterone or Nebido in particular, Z-track is worth the small additional procedural complexity.

Site selection for IM oil injection

Three IM sites are commonly used for self-administered oil-based testosterone in adults:

• Ventrogluteal (gluteus medius/minimus) — the safest IM site by anatomical landmarks, away from major nerves and blood vessels. Best for larger volumes (2 mL+). Difficult to self-administer; usually requires a partner.
• Vastus lateralis (outer-front of upper thigh) — easily self-administered, well tolerated, accommodates 1–2 mL volumes comfortably.
• Dorsogluteal (upper-outer quadrant of buttock) — the classic IM site, but the published evidence has shifted away from it because of proximity to the sciatic nerve and superior gluteal artery. Still used; not the first choice for self-administration.

For routine self-injection of testosterone cypionate / enanthate at 1 mL or less, the vastus lateralis is the typical choice. For Nebido at 4 mL, ventrogluteal or dorsogluteal is required because of volume.

Common pitfalls and how to avoid them

Cold oil sticks: warming the vial first is non-negotiable for any practical workflow. Skipping it produces a 5-minute draw time and a sore thumb.

Single-needle technique

using the drawing needle for injection too is more painful and traumatic than swapping. The fresh injection needle has a sharper, undulled bevel.

Aspiration omission

for IM oil injection specifically, aspiration before injection remains the conservative practice. The shift away from aspiration applies primarily to vaccine administration in non-vascular sites; oil-depot IM is a different risk profile.

Massaging post-injection

do not. The Z-track technique is undone by massage.

Re-using needles

do not. Single-use is the published guidance, the safety case, and the standard of practice.

FAQ

Why does oil-based testosterone hurt more than insulin injections? Larger gauge, longer needle, deeper IM injection, and a viscous vehicle. The Z-track technique and warming the vial both reduce post-injection soreness.

Can I draw and inject with the same needle? You can, but you should not. Drawing through a rubber stopper dulls the bevel; the dulled needle then causes more tissue trauma at injection.

How long should I wait after injection before withdrawing? 10 seconds at the end of the injection, before pulling the needle out. This allows the tissue to seal around the channel.

Should I aspirate before injecting oil-based testosterone IM? Yes — for oil-depot IM specifically, aspiration remains the conservative practice. The shift away from aspiration applies to vaccines, not oil depots.

Does Z-track really make a difference? Yes. The Zaybak 2008 study found significantly less pain, bruising and post-injection leakage with Z-track in viscous IM injection.

A note on what we don't cover

We do not give dosing guidance for testosterone, progesterone, Nebido, or any other prescription medication. We do not advise on whether IM or SC is the right route for your prescription — that is a separate article on subcutaneous testosterone, and the route choice is your prescriber's. We do not advise on which testosterone ester is appropriate for your case. We do not source any controlled or compounded preparation; the SmPC-licensed UK products and their NHS or private prescription route are the only legitimate channels.

What we do is sell the supplies — drawing needles, injection needles, syringes, alcohol pads, sharps bins — that the procedure described above requires. For drawing-up and injection needle bundles for oil-based IM, pick up the 29G × 1/2 inch insulin syringe 100-pack or browse the full 29G product range and IM-needle catalog.

Sources

• Centers for Disease Control and Prevention, Best Practices for Injection Safety — cdc.gov
• World Health Organization, Best Practices for Injections and Related Procedures Toolkit — who.int
• Nicoll LH, Hesby A. Intramuscular Injection: An Integrative Research Review. Appl Nurs Res. 2002;15(3):149–162 — doi.org
• Zaybak A, Khorshid L. Effect of Z-track technique on local site reactions. J Adv Nurs. 2008;61(5):552–556 — doi.org
• Bayer plc, Nebido SmPC — emc
• Organon UK, Sustanon 250 SmPC — emc
• Actavis UK Ltd, Cyclogest (progesterone in oil) SmPC — emc

This article is for general information only and is not medical advice. Always consult your prescriber for guidance specific to your prescription and clinical situation.